Dynamic changes of Kisspeptin during controlled ovarian hyperstimulation (COH) in polycystic ovary syndrome patients and its correlation with COH outcomes

• by Lu Han, Yiran Wang, Yueying Li, Xiaoyan Li, Jing Zhang, Yan Zhang, Mingfei Zhao, Haixia Chen, Huiying Zhang, Yingmei Wang, Fengxia Xue, Wenyan Tian

• May 20, 2026

IGF-II, IGFBP-4, -6, and -7, and HMGB1 show changes in follicular fluid in PCOS

• by Veronica Buia, Cecilia Catellani, Stefania Croci, Beatrice Righi, Daria Morini, Angela Immacolata Falbo, Alessia Nicoli, Alessandro De Fanti, Lucia Belloni, Lorenzo Aguzzoli, Maria Teresa Villani, Chiara Sartori, Maria Elisabeth Street

• June 5, 2026

Combined metabolic-reproductive association and predictive value of AMH and TyG index in PCOS: a single-center retrospective study

• by Yu Chen, Xinyan Shi, Lin Ma, Yujie Hu, Mei Wang, Lei Shu

• July 8, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min